Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
3 participants
INTERVENTIONAL
2016-09-30
2018-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inspiratory Muscle Training in Hypercapnic COPD
NCT00291460
Inspiratory Muscle Training for Patients With Chronic Obstructive Pulmonary Disorder
NCT02673242
Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD
NCT02074813
Inspiratory Muscle Training and COPD
NCT04415788
Inspiratory Muscle Training Combined With General Exercise Training in COPD
NCT02392715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will be conducted as an a feasibility study and will examine whether inspiratory muscle training with a Power Breathe device (K3) is possible over a 6 week period in patients with COPD and chronic hypercapnia (pCO2 \> 6 kilo pascal).
IMT will be considered as feasible if 80% of the planned training sessions have been completed, and if the maximum inspiratory strength improves by an average of 10% from MIP and if patients do not experience any discomfort or increased dyspnea during training.
The training of the respiratory strength is carried out daily with an electronic handheld device (Power Breathe K3) and will consist of 2x30 inspirations per day with the resistance adjusted individually and progressively with a pressure of 30 - 50% of maximal inspiratory pressure. Training will take place in the home.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IMT-feasibility
Single arm intervention
IMT
Inspiratory muscle training for 6 weeks 2x30 breaths daily as a home based program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMT
Inspiratory muscle training for 6 weeks 2x30 breaths daily as a home based program
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have elevated pCO2 in stable phase assessed by arterial blood gas with pCO2\> 6 kPa
* Have given informed consent
* Can understand written and oral instructions
Exclusion Criteria
* Patients using variable oxygenation rate that may affect the carbon dioxide level.
* Unstable patients and at high risk of exacerbation during the investigation period
* Hospitalized patient with COPD exacerbation during the intervention period
* Patients with an expected need for change of COPD medication or oxygen supply equipment in the study period.
The participation in the study will be postponed if the patient is in a rehabilitation program
45 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Linette Marie Kofod
Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten T Kristensen, PhD
Role: STUDY_CHAIR
Copenhagen University Hospital, Hvidovre
Ejvind F Hansen, MD
Role: STUDY_CHAIR
Pulmonary Sektion, Copenhagen University Hospital, Hvidovre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Copenhagen University Hospital, Hvidovre
Hvidovre, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-16022336
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.